Skip to content

The Pelvic Floor Function and Sexual Life of the Women After Different Type of Hysterectomy

The Association of Total Hysterectomy and Disorders of Female Pelvic Floor or Sexual Function: a Survey on Pelvic Floor Function and Sexual Life for Women After Different Type of Hysterectomy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02841059
Acronym
HYS-PF-QOL
Enrollment
120
Registered
2016-07-21
Start date
2015-05-31
Completion date
2018-06-30
Last updated
2017-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Organ Prolapse, Quality of Life, Urinary Incontinence

Keywords

quality of life, urinary incontinence, POP

Brief summary

In this prospective, comparative non-randomized multiple teaching hospitals study, the investigators try to determine the relationship of total hysterectomy and Taiwanese female pelvic floor and sexual function from the view of epidemiology and clinical survey. This is an important issue that related to female autonomy, health care resources and even national health policy. The study results will help to understand whether there is unnecessary part in the current hysterectomy procedures and its potential health hazard.

Detailed description

Women with benign gynecology disease and indicated for laparoscopic hysterectomy (laparoscopic subtotal hysterectomy: LSH, laparoscopic cervical ligament sparing hysterectomy: CLSH, laparoscopic assisted vaginal hysterectomy: LAVH) are invited and explained the details of the protocol by the surgeon. The types of hysterectomy are determined by the patient and the surgeon together after discussion. All participant have to sign the informed consent. The participant will be followed up for two years after surgery. Preoperative evaluation on uterine condition, pelvic floor, questionaires were recorded. The perioperative parameters including surgical time, blood loss, and postoperative parameters such as pain score, hospitalization etc were recorded. The postoperative evaluation on pelvic floor condition, questionaires etc were also recorded at different time points.

Interventions

PROCEDURELSH

laparoscopic subtotal hysterectomy: LSH

PROCEDURECLSH

laparoscopic cervical ligament sparing hysterectomy: CLSH

PROCEDURELAVH

laparoscopic assisted vaginal hysterectomy: LAVH

Sponsors

Ministry of Science and Technology, Taiwan
CollaboratorOTHER_GOV
Buddhist Tzu Chi General Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
30 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

1. Patient who is indicated for hysterectomy due to benign gynecology disease. The participant's husband is also welcomed to join the survey of the sexual life questionnaire but this is not a necessary inclusion criteria.

Exclusion criteria

1. Suspect of or diagnosed as cancer patient 2. Age \< 30 or \> 50 years old 3. Menopausal woman or woman who is nulliparous 4. Patient with advanced pelvic floor prolapse (stage 2, 3, 4) including uterine prolapse, cystocele, enterocele, rectocele. 5. Patient with prominent urinary incontinence that affect social activity or suggested to have surgery by gynecologist or urologist. 6. Patient with severe medical diseases such as liver cirrhosis, heart failure, poor control diabetes mellitus etc. 7. Patient with severe pelvic inflammatory disease/tubo-ovarian abcess or pelvic endometriosis or history of severe pelvic adhesions. 8. Psychiatric patients 9. Patient with chronic lung disease such as bronchial asthma, bronchiectasis, chronic obstructive pulmonary disease and interstitial lung disease

Design outcomes

Primary

MeasureTime frameDescription
Quality of life changeup to 12 months after hysterectomyEvaluate the change of quality of life by questionaire --WHOQOL-BREF Taiwan version, at preoperation,1,3,6 and 12 months after hysterectomy.

Secondary

MeasureTime frameDescription
Pelvic organ prolapse changeup to 24 months after hysterectomyevaluate by Pelvic Organ Prolapse Quantification System (POP-Q) at preoperation, 6,12 and 24 months after hysterectomy.
Urinary disorders changepreoperation and 3,6 and 12 months after hysterectomyevaluate by UDI-6 short form at preoperation,3,6 and 12 months after hysterectomy.
Sexual life changepreoperation and 3,6 and 12 months after hysterectomyshort form of PISQ-9 approved by International Urogynecological Association, IUGA, at preoperation,3,6 and 12 months after hysterectomy.
Urinary incontinence status changepreoperation and 3,6 and 12 months after hysterectomyevaluate by IIQ-7 short form at preoperation,3,6 and 12 months after hysterectomy.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026